-
公开(公告)号:US12178892B2
公开(公告)日:2024-12-31
申请号:US17488810
申请日:2021-09-29
Applicant: Endocyte, Inc. , Purdue Research Foundation
Inventor: Iontcho R Vlahov , Christopher P Leamon , Philip S. Low , Garth L Parham , Qingshou Chen
IPC: A61K51/04
Abstract: Described herein are compounds, compositions, and methods for diagnosing and/or monitoring pathogenic disease using positron emission tomography. Also described are conjugates of the formula B-L-P, wherein B is a radical of a targeting agent selected from vitamin receptor binding ligands (such as folate), PSMA binding ligands, or PSMA inhibitors; L is a divalent linker comprising aspartic acid, lysine, or arginine, and P is a radical of an imaging agent or radiotherapy agent, such as a radionuclide or radionuclide containing group, or a radical of a compound capable of binding a radionuclide, such as a metal chelating group.
-
公开(公告)号:US11478797B2
公开(公告)日:2022-10-25
申请号:US16420412
申请日:2019-05-23
Applicant: Purdue Research Foundation
Inventor: Cagri A. Savran , Philip S. Low , Chun-Li Chang
IPC: B01L3/00 , G01N33/574 , G01N33/543 , G01N27/74 , G01N1/40
Abstract: A microfluidic detection system for micrometer-sized entities, such as biological cells, includes a detector component incorporating a plate with a plurality of opening, the plate separating two chambers, one in communication with a fluid source containing target cells bound to magnetic beads. The openings are sized to always permit passage of the magnetic beads therethrough into a lower one of the chambers and are further sized to always prevent passage of the target cells from the upper one of the chambers. The detector component further includes a magnet positioned to pull unbound magnetic beads through the openings and to capture target cells bound to magnetic beads on the surface of the plate. The microfluidic detection system includes a pump flowing the fluid through the detector component at high flow rates of milliliters per minute for high throughput detection of target cells.
-
公开(公告)号:US20220082553A1
公开(公告)日:2022-03-17
申请号:US17492328
申请日:2021-10-01
Applicant: Purdue Research Foundation
Inventor: Philip S. Low , Lindsay E. Kelderhouse
Abstract: The invention relates to methods and compositions for the selection of patients for therapy with an anti-inflammatory drug. More particularly, the invention relates to compositions comprising folate-imaging agent conjugates for the selection of patients for therapy with an anti-inflammatory drug, and methods and uses therefor.
-
公开(公告)号:US11162937B2
公开(公告)日:2021-11-02
申请号:US15037793
申请日:2014-11-19
Applicant: Purdue Research Foundation
Inventor: Philip S. Low , Lindsay E. Kelderhouse
Abstract: The invention relates to methods and compositions for the selection of patients for therapy with an anti-inflammatory drug. More particularly, the invention relates to compositions comprising folate-imaging agent conjugates for the selection of patients for therapy with an anti-inflammatory drug, and methods and uses therefor.
-
公开(公告)号:US11083710B2
公开(公告)日:2021-08-10
申请号:US16749827
申请日:2020-01-22
Applicant: Purdue Research Foundation
Inventor: Philip S. Low , Sumith A. Kularatne
IPC: A61K31/426 , A61K47/54 , A61K47/64 , A61K31/4745 , A61K31/475 , A61K49/00 , A61K51/04 , A61K51/08 , C07K5/08 , C07C323/52 , C07D207/416
Abstract: Described herein are prostate specific membrane antigen (PSMA) binding conjugates that are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein are pharmaceutical composition containing them and methods of using the conjugates and compositions. Also described are processes for manufacture of the conjugates and the compositions containing them.
-
公开(公告)号:US11077439B2
公开(公告)日:2021-08-03
申请号:US16275912
申请日:2019-02-14
Applicant: Purdue Research Foundation
Inventor: Cagri A. Savran , Philip S. Low , Chun-Li Chang , Wanfeng Huang
IPC: G01N33/553 , B01L3/00 , G01N33/574 , G01N33/543 , G01N27/74 , G01N1/40
Abstract: A microfluidic detection system for micrometer-sized entities, such as biological cells, includes a detector component incorporating a plate with a plurality of opening, the plate separating two chambers, one in communication with a fluid source containing target entities bound to magnetic beads. The openings are sized to always permit passage of the magnetic beads therethrough into a lower one of the chambers and are further sized to always prevent passage of the target entities from the upper one of the chambers. The detector component further includes a magnet positioned to pull unbound magnetic beads through the openings and to capture target entities bound to magnetic beads on the surface of the plate. In a further feature, the microfluidic detection system is configured to pass target molecules through the plate to be bound to a functionalized surface of the lower chamber.
-
公开(公告)号:US20200155695A1
公开(公告)日:2020-05-21
申请号:US16507713
申请日:2019-07-10
Applicant: Purdue Research Foundation
Inventor: Philip S. Low , Sumith A. Kularatne
IPC: A61K47/64 , A61K47/54 , A61K51/08 , A61K49/00 , A61K31/475 , A61K31/4745 , A61K31/426 , C07K5/08 , A61K51/04 , C07D207/416 , C07C323/52
Abstract: Described herein are prostate specific membrane antigen (PSMA) binding conjugates that are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein are pharmaceutical composition containing them and methods of using the conjugates and compositions. Also described are processes for manufacture of the conjugates and the compositions containing them.
-
公开(公告)号:US10646581B2
公开(公告)日:2020-05-12
申请号:US15990136
申请日:2018-05-25
Applicant: Purdue Research Foundation
Inventor: Philip S. Low , Sumith A. Kularatne
IPC: A61K47/64 , A61K47/54 , A61K51/04 , A61K51/08 , C07K5/08 , C07C323/52 , C07D207/416 , A61K49/00 , A61K31/426 , A61K31/4745 , A61K31/475
Abstract: Described herein are prostate specific membrane antigen (PSMA) binding conjugates that are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein are pharmaceutical composition containing them and methods of using the conjugates and compositions. Also described are processes for manufacture of the conjugates and the compositions containing them.
-
公开(公告)号:US20190160172A1
公开(公告)日:2019-05-30
申请号:US16264364
申请日:2019-01-31
Inventor: Stewart Andrew Low , Philip S. Low , Christopher Galliford , Jindrich Kopecek , Jiyan Yang
IPC: A61K47/42 , A61L27/22 , A61K9/107 , A61M5/00 , A61P19/00 , C07K7/08 , A61K31/404 , C07K7/06 , A61L27/54
CPC classification number: A61K47/42 , A61K9/1075 , A61K31/404 , A61L27/22 , A61L27/227 , A61L27/54 , A61L2400/06 , A61L2430/02 , A61M5/002 , A61P19/00 , C07K7/06 , C07K7/08
Abstract: Aspects of the present disclosure generally relate to compounds for targeting and healing bone fractures. Some of these compounds include a negatively charged oligopeptide comprising an acidic oligopeptide, a linker, which may be hydrolyzable or may be a substrate for the protease cathepsin K, and at least one molecule that promotes bone healing. In some compounds the molecule that promotes bone healing is an anabolic compound that inhibits GSK3β, in some compounds the molecule that promotes the healing of bone fracture is a pro-inflammatory agent such as PGE1. Other embodiments include methods of treating a bone fracture comprising administering a therapeutic amount of any one of the compounds disclosed herein.
-
公开(公告)号:US10279044B2
公开(公告)日:2019-05-07
申请号:US15578226
申请日:2016-05-29
Applicant: Purdue Research Foundation Office of Technology Commercialization , University of Utah Research Foundation , Jindrich Kopecek , Jiyan Yang
Inventor: Stewart Andrew Low , Philip S. Low , Christopher Galliford , Jindrich Kopecek , Jiyan Yang
IPC: A61K31/404 , C07D403/04 , C07D209/34 , C07D487/00 , A61K47/42 , A61L27/22 , A61L27/54 , C07K7/06 , C07K7/08 , A61P19/00 , A61K9/107 , A61M5/00
Abstract: Aspects of the present disclosure generally relate to compounds for targeting and healing bone fractures. Some of these compounds include a negatively charged oligopeptide comprising an acidic oligopeptide, a linker, which may be hydrolyzable or may be a substrate for the protease cathepsin K, and at least one molecule that promotes bone healing. In some compounds the molecule that promotes bone healing is an anabolic compound that inhibits GSK3β, in some compounds the molecule that promotes the healing of bone fracture is a pro-inflammatory agent such as PGE1. Other embodiments include methods of treating a bone fracture comprising administering a therapeutic amount of any one of the compounds disclosed herein.
-
-
-
-
-
-
-
-
-